Abigail Collins
Clinical Research Coordinator

I grew up in Connecticut and graduated from Fordham University in 2016, where I studied Psychology and Bioethics. My undergraduate research focused on expressive language impairment and emotion regulation in children. I am looking forward to beginning my time at MAP as a clinical research coordinator focused on studies examining treatment-resistant depression. In the future, I plan to pursue a PhD in Clinical Psychology.

Kate Collins, PhD, LCSW
Post-Doctoral Fellow, Department of Psychiatry, ISMMS

I am committed to the conduct of translational research that illuminates the neural substrates of and advances novel treatments for mood and anxiety disorders. After earning my master’s degree in social work, I joined our program as a diagnostician and rater in clinical trials of new therapies for depression and post-traumatic stress disorder. I entered the School’s doctoral program in neuroscience in 2009. As a student I used brain imaging and pharmacological challenge methodology to study the eurobiology of active avoidance learning. I completed my doctorate in October of 2013 before returning to MAP as a postdoctoral fellow.

Sara Costi, MD
Research Fellow

I graduated summa cum laude from medical school at the University of Parma in October 2010, then  enrolled in the School of Specialization in Psychiatry at the University of Parma. During my residency, I became interested in psycopathology and psycopharmacology and explored the relationship between depressive symptoms and hormonal status. I joined the Mood and Anxiety Disorders Program at the Icahn School of Medicine as research fellow, where I helped run clinical trials with patients experiencing unipolar depression and PTSD, developed expertise in the administration of structured research interviews, and assisted with background research for grant submission. I have become particularly interested in the role of pro-inflammatory cytokines in regulating brain responses to reward and anhedonia, the association between placebo response in analgesia and depression, and the investigation of new drugs for the treatment of mood and anxiety disorders.

Mora Grehl
Clinical Research Coordinator

I am originally from Taipei, Taiwan and graduated from Barnard College, Columbia University in May 2015. My undergraduate research and clinical experience focused primarily on early emotional development, and I hope to continue exploring emotion regulation in the context of adult mental health while working at MAP. I am also interested in self-representation, and how individuals perceive information that is either consistent or inconsistent with self-schema in the context of anxiety and depression. I plan to pursue a PhD in Clinical Psychology after gaining more research experience and refining my academic interests.

Megan Hoch
Clinical Research Coordinator

Originally from Chicago, I graduated from New York University in May, 2015. At NYU, I majored in psychology and minored in child and adolescent mental health studies and politics. I plan to pursue a doctoral degree in clinical psychology where I hope to study self-regulation and novel treatments for depression in adults.  

Marin Kautz
Clinical Research Coordinator

I am originally from California and I moved to New York to obtain my bachelor’s degree in psychology from Barnard College of Columbia University. I am especially interested in how trauma affects psychopathology and its potential role in suicidal behavior. I plan to pursue a PhD in clinical psychology.

Drew Kiraly, MD, PhD
Chief Resident for Research, Psychiatry, ISMMS

I am currently a third-year resident in the physician-scientist track of the psychiatry residency, and Chief Resident for Research in the Department of Psychiatry. I received a degree in neurobiology and biochemistry from Drew University, where I graduated magna cum laude and was elected to Phi Beta Kappa. Next, I worked in the Department of Molecular Psychiatry at Yale University and I co-authored multiple papers examining changes in cellular signaling processes that lead to the development of depression and addiction. I completed my MD and PhD degrees at the University of Connecticut where I published numerous papers examining how changes in the physical structure of synapses affects behaviors related to depression and fear learning. During my residency, I have initiated multiple studies including clinical research in the Mood and Anxiety Disorders Program, and basic science projects in the laboratory of molecular psychiatry. All of my research focuses on the role of inflammatory proteins and the gut microbiome in the development and progression of depressive and addictive disorders.

Ai Morishita, MD
Senior Clinical Research Coordinator

I was a staff psychiatrist at Kumamoto Prefecture Psychiatric Hospital and Osaka City University Hospital in Japan after completing my residency training at the National Center of Neurology and Psychiatry Hospital and Kumamoto University, also in Japan.

Samantha Richards
Clinical Research Coordinator

I am originally from Charlotte, North Carolina, and attended UNC Chapel Hill, where I received my bachelors degree in Psychology and Anthropology, with a minor in Linguistics. After MAP, I plan to pursue a doctoral degree in Psychology. My research interests are primarily in cognitive and affective neuroscience and include the neurological underpinnings of fear, anxiety, and depression.

Laili Soleimani, MD, MSc
Chief, Inpatient Geriatric Psychiatry Unit, The Mount Sinai Hospital
Assistant Professor of Psychiatry at ISMMS

I began my formal research experience in basic neuroscience during my graduate training at the University of Toronto where I focused on animal models of depression. Subsequently, I have pursued clinical research in parallel as part of my residency training in psychiatry in the Physician-Scientist Research Track. I have been collaborating with the Mood and Anxiety Disorders Program (MAP) and Alzheimer's Disease Research Center  throughout my residency and fellowship training. At MAP, I have been involved in multiple clinical studies on novel treatment modalities for mood and anxiety disorders. Currently, I am on the clinical faculty at the Department of Psychiatry at Mount Sinai working with inpatient geriatric patients and those with complicated medical co-morbidities. My areas of interest include the pathophysiology of depression and suicide as well as the intersection of mood and cognitive disorders. At the MAP, we are initiating a series of studies on suicidality in an inpatient setting, where patients present at the peak of their symptomatology. We recently completed a randomized clinical trial on the anti-suicidal effect of ketamine, and we hope to explore the biomakers of suicide.

Nicholas T. Van Dam, PhD
Post-Doctoral Fellow, Department of Psychiatry, ISMMS

I trained formally as a clinical psychologist with a focus on the assessment and treatment of depression, anxiety, and related conditions. During my early graduate work, I developed expertise in psychometrics and advanced statistical analysis. Later in my graduate career, and into my early post-graduate career, I trained in the numerous aspects of collecting and analyzing functional magnetic resonance imaging data, both task-based and resting state. The intersection of working with and assessing high prevalence psychiatric conditions, measuring subjective experience, and examining the neurophysiological basis of cognitive and affective functions has prepared me for the interdisciplinary nature of clinical neuroscience and efforts to classify and predict mental illness. Since joining the Mood and Anxiety Disorders Program, I have helped spearhead new initiatives to optimize behavioral data collection and neuroimaging analyses. I am pursuing research on understanding the clinical phenomenology and neurobiology of mood and anxiety disorders.

Elizabeth Wade
Clinical Research Coordinator

I am originally from Seattle, Washington, and I attended Barnard College, where I double majored in religion and psychology. My undergraduate thesis in the religion department focused on gender and fundamentalist religion in the United States. I plan to pursue a PhD in Clinical Psychology; my research interests include anhedonia and perseverative thought/behavior across the spectrum of mood and anxiety disorders.